Particularly, DEGs that have been shown to have roles in molecular pathways leading to NASH, through inflammation, are expressed in a contradictory manner suggesting depletion of Efcab4b could be protective especially as previous studies suggest a role for Rab46 in inflammation. Here, CRACR2A is linked to metabolic dysfunction-associated steatohepatitis.